|
ACER3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.409600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.942500E-03 |
| Normal-vs-Stage2 |
2.976200E-01 |
| Normal-vs-Stage3 |
5.536600E-01 |
| Normal-vs-Stage4 |
2.433700E-02 |
| Stage1-vs-Stage2 |
1.738080E-02 |
| Stage1-vs-Stage3 |
1.340420E-01 |
| Stage1-vs-Stage4 |
6.437800E-01 |
| Stage2-vs-Stage3 |
1.741440E-01 |
| Stage2-vs-Stage4 |
4.868200E-02 |
| Stage3-vs-Stage4 |
2.344400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.074000E-02 |
| Normal-vs-AfricanAmerican |
3.782400E-01 |
| Normal-vs-Asian |
1.279230E-01 |
| Caucasian-vs-AfricanAmerican |
3.719200E-01 |
| Caucasian-vs-Asian |
7.484800E-01 |
| AfricanAmerican-vs-Asian |
5.390600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.462800E-03 |
| Normal-vs-Female |
2.861400E-01 |
| Male-vs-Female |
5.783400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.283600E-02 |
| Normal-vs-Extreme_Weight |
1.988520E-04 |
| Normal-vs-Obese |
7.990600E-01 |
| Normal-vs-Extreme_Obese |
3.755200E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.808180E-01 |
| Normal_Weight-vs-Obese |
1.816210E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.208400E-01 |
| Extreme_Weight-vs-Obese |
3.940900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.713600E-01 |
| Obese-vs-Extreme_Obese |
8.606200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.488400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.438400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.562700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.141800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.350800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.029800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.498800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.363930E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.015160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.005000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.651600E-02 |
| Normal-VS-Type2 PRCC |
1.321740E-02 |
| Normal-VS-KIRP CIMP |
3.037400E-01 |
| Normal-VS-Unclassified PRCC |
5.565800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.671800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.656000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.217410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.009540E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.979700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.720800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.996300E-02 |
| Normal-vs-N1 |
8.011200E-01 |
| Normal-vs-N2 |
1.064030E-01 |
| N0-vs-N1 |
2.680600E-01 |
| N0-vs-N2 |
5.761600E-01 |
| N1-vs-N2 |
3.834600E-01 |
|
|
